As a sum of the above, the most concordant findings regarding EAE/MS can be linked to PPARγ, implicating its potential role as an endogenous immunomodulatory molecule as well as a biomarker with potential human clinical relevance. This evidence concerns the gene PPARG and myeloid sarcoma.